
Episode 13: You get blinatumomab! You get blinatumomab!
WolverHeme Happy Hour
00:00
BLIN at Tumumab: The Best Chemotherapy for Hyper C VAD
I think there's a lot of compelling arguments, you know, given with certain patients to choose one regimen versus the other. These are completely different chemo therapy backbones. It might be that the myelos suppression with a hyper C VAD just completely knocks out your effector cells. And it's become, and you may not see as much in the way of BLIN at Tumumab benefit.
Transcript
Play full episode